• Executive Summary o Market Overview • Market Landscape o Market ecosystem o Value chain analysis • Market Sizing o Market definition o Market segment analysis o Market size 2019 o Market outlook: Forecast for 2019 - 2024 • Five Forces Analysis o Five Forces Summary o Bargaining power of buyers o Bargaining power of suppliers o Threat of new entrants o Threat of substitutes o Threat of rivalry o Market condition • Market Segmentation by Product o Market segments o Comparison by Product placement o Consumables - Market size and forecast 2019-2024 o Instruments - Market size and forecast 2019-2024 o Market opportunity by Product • Customer landscape o Overview • Geographic Landscape o Geographic segmentation o Geographic comparison o North America - Market size and forecast 2019-2024 o Europe - Market size and forecast 2019-2024 o Asia - Market size and forecast 2019-2024 o ROW - Market size and forecast 2019-2024 o Key leading countries o Market opportunity by geography • Drivers, Challenges, and Trends o Market drivers o Volume driver - Demand led growth o Volume driver - Supply led growth o Volume driver - External factors o Volume driver - Demand shift in adjacent markets o Price driver - Inflation o Price driver - Shift from lower to higher priced units o Market challenges o Market trends • Vendor Landscape o Overview o Vendor landscape o Landscape disruption • Vendor Analysis o Vendors covered o Market positioning of vendors o Agilent Technologies Inc. o bioMérieux SA o Bio-Rad Laboratories Inc. o BIOTECON Diagnostics GmbH o Danaher Corp. o Hygiena LLC o Minerva Biolabs GmbH o QIAGEN NV o R-Biopharm AG o Thermo Fisher Scientific Inc. • Appendix o Scope of the report o Currency conversion rates for US$ o Research methodology o List of abbreviations Exhibits • 1.Key Finding 1 • 2.Key Finding 2 • 3.Key Finding 3 • 4.Key Finding 4 • 5.Key Finding 5 • 6.Key Finding 6 • 7.Key Finding 7 • 8.Market in focus • 9.Parent market • 10.Market characteristics • 11.Product / Service portfolio of key vendors included in the market definition • 12.Market segments • 13.Global - Market size and forecast 2019 - 2024 ($ million) • 14.Global market: Year-over-year growth 2019 - 2024 (%) • 15.Five forces analysis 2019 & 2024 • 16.Bargaining power of buyers • 17.Bargaining power of suppliers • 18.Threat of new entrants • 19.Threat of substitutes • 20.Threat of rivalry • 21.Market condition - Five forces 2019 • 22.Product placement - Market share 2019-2024 (%) • 23.Comparison by Product placement • 24.Consumables - Market size and forecast 2019-2024 ($ million) • 25.Consumables - Year-over-year growth 2019-2024 (%) • 26.Instruments - Market size and forecast 2019-2024 ($ million) • 27.Instruments - Year-over-year growth 2019-2024 (%) • 28. Market opportunity by Product • 29.Customer landscape • 30.Market share by geography 2019-2024 (%) • 31.Geographic comparison • 32.North America - Market size and forecast 2019-2024 ($ million) • 33.North America - Year-over-year growth 2019-2024 (%) • 34.Europe - Market size and forecast 2019-2024 ($ million) • 35.Europe - Year-over-year growth 2019-2024 (%) • 36.Asia - Market size and forecast 2019-2024 ($ million) • 37.Asia - Year-over-year growth 2019-2024 (%) • 38.ROW - Market size and forecast 2019-2024 ($ million) • 39.ROW - Year-over-year growth 2019-2024 (%) • 40.Key leading countries • 41.Market opportunity by geography ($ million) • 42.Impact of drivers • 43.Impact of challenges • 44.Landscape disruption • 45.Industry risks • 46.Vendors covered • 47.Market positioning of vendors • 48.Agilent Technologies Inc. - Overview (1/3) • 49.Agilent Technologies Inc. - Overview (2/3) • 50.Agilent Technologies Inc. - Overview (3/3) • 51.Agilent Technologies Inc. - Business segments • 52.Agilent Technologies Inc. - Key offerings • 53.Agilent Technologies Inc. - Key customers • 54.Agilent Technologies Inc. - Segment focus • 55.bioMérieux SA - Overview (1/3) • 56.bioMérieux SA - Overview (2/3) • 57.bioMérieux SA - Overview (3/3) • 58.bioMérieux SA - Business segments • 59.bioMérieux SA - Key offerings • 60.bioMérieux SA - Key customers • 61.bioMérieux SA - Segment focus • 62.Bio-Rad Laboratories Inc. - Overview (1/3) • 63.Bio-Rad Laboratories Inc. - Overview (2/3) • 64.Bio-Rad Laboratories Inc. - Overview (3/3) • 65.Bio-Rad Laboratories Inc. - Business segments • 66.Bio-Rad Laboratories Inc. - Key offerings • 67.Bio-Rad Laboratories Inc. - Key customers • 68.Bio-Rad Laboratories Inc. - Segment focus • 69.BIOTECON Diagnostics GmbH - Overview (1/3) • 70.BIOTECON Diagnostics GmbH - Overview (2/3) • 71.BIOTECON Diagnostics GmbH - Overview (3/3) • 72.BIOTECON Diagnostics GmbH - Product and service • 73.BIOTECON Diagnostics GmbH - Key offerings • 74.BIOTECON Diagnostics GmbH - Key customers • 75.BIOTECON Diagnostics GmbH - Segment focus • 76.Danaher Corp. - Overview (1/3) • 77.Danaher Corp. - Overview (2/3) • 78.Danaher Corp. - Overview (3/3) • 79.Danaher Corp. - Business segments • 80.Danaher Corp. - Key offerings • 81.Danaher Corp. - Key customers • 82.Danaher Corp. - Segment focus • 83.Hygiena LLC - Overview (1/3) • 84.Hygiena LLC - Overview (2/3) • 85.Hygiena LLC - Overview (3/3) • 86.Hygiena LLC - Product and service • 87.Hygiena LLC - Key offerings • 88.Hygiena LLC - Key customers • 89.Hygiena LLC - Segment focus • 90.Minerva Biolabs GmbH - Overview (1/3) • 91.Minerva Biolabs GmbH - Overview (2/3) • 92.Minerva Biolabs GmbH - Overview (3/3) • 93.Minerva Biolabs GmbH - Business segments • 94.Minerva Biolabs GmbH - Key offerings • 95.Minerva Biolabs GmbH - Key customers • 96.Minerva Biolabs GmbH - Segment focus • 97.QIAGEN NV - Overview (1/3) • 98.QIAGEN NV - Overview (2/3) • 99.QIAGEN NV - Overview (3/3) • 100.QIAGEN NV - Business segments • 101.QIAGEN NV - Key offerings • 102.QIAGEN NV - Key customers • 103.QIAGEN NV - Segment focus • 104.R-Biopharm AG - Overview (1/3) • 105.R-Biopharm AG - Overview (2/3) • 106.R-Biopharm AG - Overview (3/3) • 107.R-Biopharm AG - Business segments • 108.R-Biopharm AG - Key offerings • 109.R-Biopharm AG - Key customers • 110.R-Biopharm AG - Segment focus • 111.Thermo Fisher Scientific Inc. - Overview (1/3) • 112.Thermo Fisher Scientific Inc. - Overview (2/3) • 113.Thermo Fisher Scientific Inc. - Overview (3/3) • 114.Thermo Fisher Scientific Inc. - Business segments • 115.Thermo Fisher Scientific Inc. - Key offerings • 116.Thermo Fisher Scientific Inc. - Key customers • 117.Thermo Fisher Scientific Inc. - Segment focus • 118.Currency conversion rates for US$ • 119.Research Methodology • 120.Validation techniques employed for market sizing • 121.Information sources • 122.List of abbreviations

Agilent Technologies Inc.,bioMérieux SA,Bio-Rad Laboratories Inc.,BIOTECON Diagnostics GmbH,Danaher Corp.,Hygiena LLC,Minerva Biolabs GmbH,QIAGEN NV,R-Biopharm AG,Thermo Fisher Scientific Inc.